Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

39.31
+0.94502.46%
Post-market: 38.72-0.5850-1.49%16:10 EDT
Volume:553
Turnover:21.44K
Market Cap:2.95M
PE:- -
High:39.31
Open:38.72
Low:38.72
Close:38.36
52wk High:45.88
52wk Low:25.71
Shares:75.00K
Float Shares:75.00K
Volume Ratio:0.03
T/O Rate:0.74%
Dividend:0.62
Dividend Rate:1.58%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Pharming wins FDA nod to extend Joenja use to younger APDS children

TIPRANKS
·
Sep 12

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

TIPRANKS
·
Sep 12

Political and General News Events from September 11

Reuters
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Dow Jones
·
Sep 10

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Amgen to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 10

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Reuters
·
Sep 09

Sanofi, Regeneron Could Extend Dupixent Patent

Dow Jones
·
Sep 09

Regeneron Pharmaceuticals, Inc. : Bmo Raises Target Price to $920 from $800

THOMSON REUTERS
·
Sep 09

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)

TIPRANKS
·
Sep 09

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 09

LIVE Markets-Europe Before the Bell: Eyeing Another Soft Open

Reuters
·
Sep 09

Amgen Shares Plunge to Decade Low After Rival Drug Trial Fails, BMO Cuts Rating

Stock News
·
Sep 09

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

TIPRANKS
·
Sep 09

Money Quote: a Bad Day for Amgen Stock

Dow Jones
·
Sep 09